Stay updated on Pembrolizumab Maintenance in sNSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.

Latest updates to the Pembrolizumab Maintenance in sNSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedThe page revision label was updated from v3.4.3 to v3.5.0. This change does not affect study details or core page behavior.SummaryDifference0.1%

- Check28 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check35 days agoChange DetectedNo additions or deletions were detected; the page content appears unchanged.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision: v3.4.2 was added; prior updates and notices, including Revision: v3.4.1 and a government funding/operating status notice, were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check63 days agoChange DetectedAdded a general site notice about potential delays due to government funding and updated the revision tag to v3.4.1, removing the previous v3.4.0 tag. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange DetectedThe page now shows a glossary toggle and new QC metadata (Last Update Submitted that Met QC Criteria) and a new revision (Revision: v3.4.0), while older QC metadata (Last Update Submitted that met QC Criteria), No FEAR Act data, and the previous revision (v3.3.4) were removed.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Maintenance in sNSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.